MENU

The Comprehensive A.I.-Driven Genomic Landscape for ALS - Implications for Drug Discovery and Development

C.E. Credits: P.A.C.E. CE Florida CE
Speaker

Abstract

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease affecting approximately 1 in 50,000 people worldwide. About 10% of these cases are found to have a hereditary component, but lack of routine genetic testing for those with family history suggests that the number could be much higher. Having better clarity into which genes play a role in disease causation, and by what molecular mechanism, is the basis for precision medicine. This, coupled with an understanding of the clinical presentation of the disease based on genotype and progression, helps clinical and pharma researchers to improve patient selection for clinical trials and, ultimately, better diagnose and treat ALS patients. However, there has not yet been a systematic and comprehensive investigation of all genetic variants across the most prevalent ALS-associated genes.

To overcome this limitation, we present the most comprehensive genomic landscape of 36+ ALS-associated genes and a complete characterization of all disease-causing variants, assessed to clinical standards and annotated for actionability. Dr. Mark Kiel will present the results of this curation effort and what it may mean for improving ALS diagnosis and treatment.

Learning Objectives:

1. Learn how the genetic heterogeneity of ALS has ramifications for clinical practice

2. See what a genomic landscape is and how a combination of A.I. and manual techniques can be used to produce one

3. Review the results of the ALS Genomic Landscape, highlighting key findings and their implications for drug development


Show Resources
You May Also Like
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
JUN 21, 2022 6:00 AM PDT
JUN 21, 2022 6:00 AM PDT
Date: June 21, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) The global understanding and practice of medicine is currently undergoing a revolutionary change. This shift to precision...
AUG 10, 2022 10:00 AM PDT
AUG 10, 2022 10:00 AM PDT
Date: August 10, 2022 Time: 10:00am PDT, 1:00pm EDT The global pandemic has increased focus and scrutiny on molecular diagnostic assay development, resulting in a need for assays that provid...
APR 28, 2022 8:00 AM PDT
APR 28, 2022 8:00 AM PDT
Date: April 28, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Human pluripotent stem cells (PSCs) and their derivatives hold great potentials in...
AUG 16, 2022 11:00 AM PDT
AUG 16, 2022 11:00 AM PDT
Date: August 16, 2022 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEST) Understanding genomic variation in the context of cancer is paramount to identifying disease drivers and informing pers...
OCT 11, 2022 8:00 AM PDT
C.E. CREDITS
OCT 11, 2022 8:00 AM PDT
Date: October 11, 2022 Time: 8:00am (PDT), 11:00pm (EDT), 5:00pm (CEST) Multiomic profiling of cell populations at single-cell resolution is revolutionizing scientists’ understanding o...
Loading Comments...
Show Resources